c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellular Carcinoma (HCC). Caveolin 1 (CAV1), a plasma membrane protein that modulates signal transduction molecules, is also overexpressed in HCC. The aim of this study was to investigate biological and clinical significance of co-expression and activation of c-Met and CAV1 in HCC. We showed that c-Met and CAV1 were co-localized in HCC cells and HGF treatment increased this association. HGF-triggered c-Met activation caused a concurrent rise in both phosphorylation and expression of CAV1. Ectopic expression of CAV1 accelerated c-Met signaling, resulted in enhanced migration, invasion, and branching-morphogenesis. Silencing of CAV1 downregulated c-...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellu...
c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellu...
<div><p>c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hep...
c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellu...
PubMed ID: 25148256c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregul...
WOS: 000341230600039PubMed ID: 25148256c-Met, the receptor for Hepatocyte Growth Factor (HGF), overe...
<p><b>A.</b> HGF induced association of CAV1 with c-Met. Serum starved SNU-449 cells were exposed to...
Conference Theme: Systems Biology Approaches to Cancer and Metabolic DiseaseBACKGROUND AND AIMS: Cav...
c-MET is the membrane receptor for hepatocyte growth factor (HGF), also known as scatter factor or t...
c-MET is the membrane receptor for hepatocyte growth factor (HGF), also known as scatter factor or t...
Caveolin-1 (CAV1) has significant roles in many primary tumors and metastasis, despite the fact that...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellu...
c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellu...
<div><p>c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hep...
c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregulated in Hepatocellu...
PubMed ID: 25148256c-Met, the receptor for Hepatocyte Growth Factor (HGF), overexpressed and deregul...
WOS: 000341230600039PubMed ID: 25148256c-Met, the receptor for Hepatocyte Growth Factor (HGF), overe...
<p><b>A.</b> HGF induced association of CAV1 with c-Met. Serum starved SNU-449 cells were exposed to...
Conference Theme: Systems Biology Approaches to Cancer and Metabolic DiseaseBACKGROUND AND AIMS: Cav...
c-MET is the membrane receptor for hepatocyte growth factor (HGF), also known as scatter factor or t...
c-MET is the membrane receptor for hepatocyte growth factor (HGF), also known as scatter factor or t...
Caveolin-1 (CAV1) has significant roles in many primary tumors and metastasis, despite the fact that...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...
Hepatocellular carcinoma (HCC) is a heterogeneous tumour associated with poor prognostic outcome. Ca...